Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Comi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Pain Research|May 13, 2017
Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritisEleonora Comi, Marco Lanza, Flora Ferrari, et al.
Neurorehabilitation and Neural Repair|March 14, 2007
Impaired short-term motor learning in multiple sclerosis: evidence from virtual realityLetizia Leocani, Eleonora Comi, Pietro Annovazzi, et al.
Human Brain Mapping|January 29, 2005
Visual evoked potentials may be recorded simultaneously with fMRI scanning: A validation studyEleonora Comi, Pietro Annovazzi, Ana Martins Silva, et al.
British Journal of Pharmacology|March 11, 2020
Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent modelsEmanuele Sala, Flora Ferrari, Marco Lanza, et al.
European Journal of Pharmacology|November 24, 2015
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulationGiovanni Caprioli, Valerio Mammoli, Massimo Ricciutelli, et al.
Arthritis Research & Therapy|March 2, 2018
Pharmacological characterisation of CR6086, a potent prostaglandin E<sub>2</sub> receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drugGianfranco Caselli, Albino Bonazzi, Marco Lanza, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Pain Research|May 13, 2017
Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritisEleonora Comi, Marco Lanza, Flora Ferrari, et al.
Neurorehabilitation and Neural Repair|March 14, 2007
Impaired short-term motor learning in multiple sclerosis: evidence from virtual realityLetizia Leocani, Eleonora Comi, Pietro Annovazzi, et al.
Human Brain Mapping|January 29, 2005
Visual evoked potentials may be recorded simultaneously with fMRI scanning: A validation studyEleonora Comi, Pietro Annovazzi, Ana Martins Silva, et al.
British Journal of Pharmacology|March 11, 2020
Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent modelsEmanuele Sala, Flora Ferrari, Marco Lanza, et al.
European Journal of Pharmacology|November 24, 2015
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulationGiovanni Caprioli, Valerio Mammoli, Massimo Ricciutelli, et al.
Arthritis Research & Therapy|March 2, 2018
Pharmacological characterisation of CR6086, a potent prostaglandin E<sub>2</sub> receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drugGianfranco Caselli, Albino Bonazzi, Marco Lanza, et al.
Pageof 1